AusperBio
About AusperBio
A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Round | Date | Amount | Investors |
---|---|---|---|
Series B | May 29, 2025 | $50.0M | Unknown |
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
New Raise 🏛️ Company: AusperBio 🔗 Website: https://t.co/okGtQ9eCwc 📊 Amount: $50 Million 🔄 Round: Series B+ 🧮 Valuation: N/A ⚙️ Industry: Biotechnology
AusperBio, a San Francisco, CA- and Hangzhou, China-based clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, raised $50M in Series B+ funding https://t.co/bM53foWP8h
Similar Startups
BioTroy Therapeutics
89% matchBioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
One Biosciences
88% matchOne Biosciences is a biotechnology company focused on innovative solutions in the life sciences sect...
Fore Biotherapeutics
88% matchFore Biotherapeutics is a biotechnology company focused on developing innovative therapies for patie...
BillionToOneInc
87% matchA biotech company focused on diagnostics, specializing in innovative solutions for genetic testing a...